Zobrazeno 1 - 10
of 877
pro vyhledávání: '"35"'
Autor:
Alain Delmer, Nicolas Boissel, Aliénor Xhaard, Jérôme Larghero, Gérard Socié, Marie Sebert, R P de Latour, Chantal Himberlin, Lionel Adès, Emmanuel Raffoux, Marie Robin, Hervé Dombret, Nathalie Dhedin, Pierre Fenaux, Raphaël Porcher
Publikováno v:
Bone Marrow Transplantation. 50:74-81
Allogeneic hematopoietic stem cell transplantation provides the best chance of long-term survival for patients with AML, but is associated with an unpredictable risk of treatment-related mortality. From January 2000 to December 2010, we compared the
Autor:
Tang-Her Jaing, Pei-Kwei Tsay, Hung-Tao Chung, Chao-Ping Yang, Yu-Chuan Wen, Iou-Jih Hung, Shih-Hsiang Chen
Publikováno v:
Bone marrow transplantation. 47(1)
Our study was designed to prospectively determine whether or not unrelated cord blood transplantation (CBT) can produce outcomes comparable to related donor transplantation for children with β-thalassaemia. In 35 patients, 40 transplants were perfor
Publikováno v:
Annals of hematology. 83(1)
Blood products should be irradiated during allogeneic stem cell transplantation and before performing autologous stem cell harvest for prevention of acute transfusion-associated graft-versus-host disease (TA-GVHD). Usually, irradiation of all blood p
Autor:
L Wood, Peter Jacobs
Publikováno v:
Bone marrow transplantation. 42
Bone marrow was the traditional graft source when we introduced these procedures to South Africa. Technical details were established using rabbits as the experimental model with translation into a formally structured clinical programme at the Univers
Autor:
Raphaël Porcher, Régis Peffault de Latour, Lionel Ades, Emmanuel Raffoux, Alain Delmer, Gérard Socié, Jérôme Larghero, Chantal Himberlin, Hervé Dombret, Marie Robin, Marie Sebert, Pierre Fenaux, Nathalie Dhedin, Aliénor Xhaard
Publikováno v:
Blood. 120:3103-3103
Abstract 3103 Introduction: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) provides the best chance of long-term survival for patients with intermediate or high-risk acute myeloid leukemia (AML). The major limitation of this procedure is t
Autor:
H. Jardel, S. Le Tortorec, Anne-Sophie Moreau, Claude-Eric Bulabois, Noel-Jean Milpied, J-L Harousseau, Marc-André Mahé, H Maisoneuve, Béatrice Mahé, M. J. Rapp, Philippe Moreau, Mohamed Hamidou, Benoit Dupas, Sylvain Bourdin, Nadine Morineau
Publikováno v:
Leukemialymphoma. 30(3-4)
Thirty-five adult patients with high-risk HD (HD) defined by (1) Ann Arbor stage IV or bulky nodal disease (tumor/thorax ratio > 0.45) and (2) no or partial response (PR) (< 75%) to the initial 3 courses of ABVD, received an early intensive therapy w
Autor:
Akshay Sharma, R. Chowdhury, Amelia Langston, Edmund K. Waller, Sagar Lonial, Christopher R. Flowers, Michael Graiser, Hongzheng Zhang, Minghui Duan, Ann E. Haight
Publikováno v:
Biology of Blood and Marrow Transplantation. 18:S296
Autor:
Atsuko Tsukamoto, Fumio Kawano, Shoichi Nagakura, Yoshiko Inoue, Toshiro Kawakita, Takahiro Matsui, Michihiro Hidaka, Tetsuyuki Kiyokawa, Tatsunori Sakai, Shigeki Takemoto
Publikováno v:
Blood. 110:5037-5037
Adult T cell leukemia/lymphoma (ATL) has a high incident in Japanese. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) against ATL made the patients’ survival longer than chemotherapy alone. Actually, some of them became long survivor
Publikováno v:
Blood. 110:4420-4420
BACKGROUND: Post-transplant lymphoproliferative diseases (PTLD) are a combination of diseases characterized by the proliferation of lymphoid cells that occur in the context of post-transplant immunosuppression. Primary infection by Epstein Barr Virus
Publikováno v:
Therapeutic Apheresis and Dialysis. 9:91-91
Objectives The aim of this retrospective study is a 4-year survey of kidney transplantation since January 2000 when Slovenia became an active member of the Eurotransplant. Methods We reviewed all kidney transplants between January 2000 and December 2